FibroBiologics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FibroBiologics, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $2.86M.
- FibroBiologics, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $750.00K, a 200.00% increase year-over-year.
- FibroBiologics, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $250.00K, a 91.13% decline year-over-year.
- FibroBiologics, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $5.05M.
- FibroBiologics, Inc. stock issued during period, value, new issues for fiscal 2025 was $250.00K, a 96.85% decline from fiscal 2024.
- FibroBiologics, Inc. stock issued during period, value, new issues for fiscal 2024 was $7.92M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $2.86M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $750.00K 10-Q · filed 2026-07-31 | |
| 2025-12-31 | $250.00K 10-K · filed 2026-02-24 | |
| 2025-03-31 | $250.00K 10-Q · filed 2026-07-31 | |
| 2024-12-31 | $7.92M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $5.05M 10-Q · filed 2025-10-31 | |
| 2024-03-31 | $2.82M 10-Q · filed 2025-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |